Comparative Pharmacology
Head-to-head clinical analysis: ACTICORT versus DEXACEN 4.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ACTICORT versus DEXACEN 4.
ACTICORT vs DEXACEN-4
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Topical corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive actions. Suppresses cytokine production and inflammatory mediators via glucocorticoid receptor binding.
Dexamethasone is a glucocorticoid receptor agonist that binds to the glucocorticoid receptor, leading to increased transcription of anti-inflammatory proteins and suppression of pro-inflammatory mediators.
5-60 mg orally once daily, or divided twice daily, depending on condition severity and response.
Dexamethasone 4 mg orally or intravenously every 6-8 hours; typical adult dose is 4-20 mg/day in divided doses, depending on condition.
None Documented
None Documented
1.5-2.5 hours; prolonged in hepatic impairment (up to 10 hours) and renal impairment (up to 6 hours)
3-4 hours; prolonged to 6-8 hours in renal impairment (CrCl <30 mL/min)
Renal (70% as unchanged drug and metabolites), biliary/fecal (30%)
Renal: 65-80% as unchanged drug; Biliary: 10-15% as metabolites; Fecal: <5%
Category C
Category C
Corticosteroid
Corticosteroid